Bispezifische Antikörper: Hoffnungsträger in der Krebsimmuntherapie
Crossref DOI link: https://doi.org/10.1007/s12268-021-1618-0
Published Online: 2021-09-04
Published Print: 2021-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Stadlbauer, Katharina
Stadlmayr, Gerhard
Rüker, Florian
Wozniak-Knopp, Gordana
Text and Data Mining valid from 2021-09-01
Version of Record valid from 2021-09-04
Article History
First Online: 4 September 2021